B. Brockstein - Concepedia

Author

B. Brockstein

Also Known As

B Brockstein, B. Brockstein, B.E Brockstein, BE Brockstein

Publications

303

Citations

H-Index

Concepts

All Affiliations

B. Brockstein is an author at University of Chicago specializing in oncology, medicine, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	289
2	Pathology	2	2	67
3	Health Sciences	1	1	79
4	Head And Neck Surgery	1	1	99
5	Pharmacology	1	1	44

B. Brockstein

Publications

289

Citations

H-Index

Page 1

	Year	Citations
NCCN Practice Guidelines for Head and Neck Cancers. David G. Pfister, K.K. Ang, B. Brockstein, PubMed MedicineCancer DiagnosisNeck PathologyHead And Neck CancerHead And Neck Squamous Cell Carcinoma	2000	99
Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors B. Brockstein, Clayton M. Smiley, Jafar Al‐Sadir, Bone Marrow Transplantation Cardiovascular ToxicityMedicineBreast CancerHigh-dose ChemotherapyMetronomic Chemotherapy	2000	79
An open-label multicenter phase II study of bevacizumab for the treatment of angiosarcoma Mark Agulnik, Scott H. Okuno, Margaret von Mehren, Journal of Clinical Oncology OncologyBevacizumab 15New TherapiesMetronomic TherapyTumor Immunity	2009	46
A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer B. Brockstein, Daniel J. Haraf, Kerstin Stenson, Annals of Oncology Poor Prognosis HeadMedicineFactor SupportPharmacologyPharmacotherapy	2000	44
Brivanib (BMS-582664) in advanced soft-tissue sarcoma (STS): Biomarker and subset results of a phase II randomized discontinuation trial. G. K. Schwartz, Robert G. Maki, Mark J. Ratain, Journal of Clinical Oncology Subset ResultsPrognostic BiomarkersPhase IiProgressive DiseaseMedicine	2011	21

Page 1